前往化源商城

383150-41-2 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:N/A
External ID: SERCaMPGLuc-p1-antagonist
Protocol: PROTOCOL TABLES
SEQUENCE No. (1, 2, 3, etc.); PARAMETER (e.g., Cells, Incubation, Reagent, etc.); VALUE and DESCRIPTION.
1; Reagent; 5 uL; 1000 SH-SY5Y cells per wells
2; Time; 5 hour; 37C, 5% CO2
3; Compound; 23 nL; Control inhibitor / compound library
4; Time; 16 hour; 37C, 5% CO2
5; Reagent; 100 nM; Thapsigargin
6; Time; 4 hour; 37C, 5% CO2
7; Reagent; 1 uL; 0.5x coelenterazine
8; Detection; Luminescence; ViewLux imaging system

NOTES (numbers refer to sequence above)
1; SH-SY5Y human neuroblastoma cells stably expressing GLuc-SERCaMP (SH-SY5Y-GLuc-ASARTDL) cells were seeded in 1,536 well white tissue culture treated plates (Corning, Cat# 7464) in DMEM-high glucose-sodium pyruvate (ThermoFisher Scientific, Cat #10569) supplemented with 10% bovine growth serum (Hyclone), 10 U/ml penicillin (Gibco), 10 ug/ml streptomycin (Gibco), and 20 mM HEPES.
2; Assay plates were incubated for 5 hour at 37C in a humidified incubator containing 5% CO2.
3; qHTS libraries (23 nl, final concentrations of 1.53 uM, 7.67 uM, 38.3 uM) or controls (neutral control: DMSO, positive control: dantrolene) were added using a Kalypsis pin-tool Robotic System equipped with 1536 pinheads.
4; Cells were then incubated for 16 hours at 37C, 5% CO2.
5; Thapsigargin was added at 100 nM to deplete ER calcium stores.
6; Cells were incubated for 4 hour (37oC, 5% CO2)
7; Gaussia luciferase in the medium was measured by adding 1 ul of 0.5x coelenterazine (final concentration 0.07x) prepared in Gaussia Luciferase Glow Assay Buffer (Pierce), without addition of the Cell Lysis Buffer Reagent.
8; Luminescence was measured using a ViewLux high-432 throughput CCD imaging system (Perkin Elmer) equipped with clear filters. Compounds exhibiting inhibitory activity (defined as curve class -1.1, -1.2, -1.3, -1.4, -2.1, -2.2, -2.3, -2.4, -3) were identified by normalizing plate-wise to corresponding intra-plate controls (neutral control = Tg only; positive control (100% inhibition) = DMSO vehicle) with percent activity derived using in-house software (https://tripod.nih.gov/curvefit). The same controls were also used for the calculation of the Z' factor, a measure of assay quality control, as previously described (Zhang et al., 1999). For the initial validation of activity in the SERCaMP assays, hits from the primary screen were assayed again at 11-concentrations (1.3 nM - 76.6 uM). SH-SY5Y-GLuc-SERCaMP cells were assayed for ER Ca2+ depletion as outlined above.

Reference:
1. Zhang, J.H., Chung, T.D., and Oldenburg, K.R. (1999). A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4, 67-73.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = -1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 || ratio.curve_class == -2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0000259387 uMActivity at 0.0000710850 uMActivity at 0.0001271514 uMActivity at 0.0003024044 uMActivity at 0.0005030064 uMActivity at 0.0006524306 uMActivity at 0.00193 uMActivity at 0.00341 uMActivity at 0.00584 uMActivity at 0.010 uMActivity at 0.018 uMActivity at 0.052 uMActivity at 0.078 uMActivity at 0.156 uMActivity at 0.276 uMActivity at 0.478 uMActivity at 0.883 uMActivity at 1.507 uMActivity at 3.884 uMActivity at 7.354 uMActivity at 12.96 uMActivity at 21.63 uMActivity at 38.41 uMActivity at 76.33 uMActivity at 137.0 uMActivity at 204.0 uMCompound QC
Inhibitor1104.966488Complete curve; high efficacy-63.51170.6658-104.96640-1.10 0 0-97.13-85.6484-112.8671-97.13QC'd by Tocris
Inhibitor0.316259.327888Complete curve; high efficacy-6.50.81-84.7193-25.3915-1.10 0 0-83.9327-75.7429-81.922-83.9327QC'd by BIOMOL
Inhibitor3.162320.498785Complete curve; high efficacy-5.54.95490.4756-107.8212-87.3224-1.10 0 0-101.1849-96.9354-114.4343-101.1849QC'd by SIGMA
Inhibitor0.749266.151166Complete curve; partial efficacy-6.125410.8229-74.6135-8.4624-1.20 0 0 0 0 0 0 0 0 0 0-67.099-7.8787-22.7216-1.4525-29.6562-23.5194-8.332-25.0891-62.4832-68.6466-63.9027-67.099QC'd by Microsource
Inhibitor121.684566Complete curve; partial efficacy-64.95490.9699-77.7873-56.1028-1.20 0 0-76.43-65.0857-78.9894-76.43QC'd by BIOMOL
Inhibitor1.12259.675865Complete curve; partial efficacy-5.951.210.9999-66.8495-7.1736-1.20 0 0-66.096-42.6313-61.4055-66.096QC'd by Vitas
Inhibitor1.995334.026364Complete curve; partial efficacy-5.74.95490.9891-73.9118-39.8855-1.20 0 0-72.1972-47.1162-75.3813-72.1972QC'd by SigmaAldrich
Inhibitor12.589337.266562Complete curve; partial efficacy-4.911-78.1117-40.8452-1.20 0 0-68.8431-44.9463-54.9089-68.8431QC'd by Tocris
Inhibitor14.125432.429762Complete curve; partial efficacy-4.851.22160.9999-88.7022-56.2725-1.20 0 0-81.3177-58.1227-66.7029-81.3177QC'd by Enzo
Inhibitor1029.898362Complete curve; partial efficacy-53.29750.9999-76.1051-46.2067-1.20 0 0-75.9694-46.234-54.866-75.9694QC'd by Microsource
Inhibitor11.220226.849761Complete curve; partial efficacy-4.954.0950.9996-65.1082-38.2585-1.20 0 0-65.0072-38.2023-43.2866-65.0072QC'd by SigmaAldrich
Inhibitor25.118945.784461Complete curve; partial efficacy-4.61.53861-101.459-55.6745-1.20 0 0-85.8367-56.2934-62.0903-85.8367QC'd by SigmaAldrich
Inhibitor31.622832.29860Complete curve; partial efficacy-4.52.18760.9999-141.8428-109.5448-1.20 0 0-129.0357-109.6207-111.066-129.0357QC'd by Microsource
Inhibitor31.622835.977260Complete curve; partial efficacy-4.51.10.9999-99.0432-63.0659-1.20 0 0-82.9526-64.2216-69.1965-82.9526QC'd by Microsource
Inhibitor35.481337.624260Complete curve; partial efficacy-4.454.95490.9762-81.2779-43.6537-1.20 0 0-66.0936-45.7944-41.8015-66.0936QC'd by Tocris
Inhibitor35.481350.188560Complete curve; partial efficacy-4.454.44950.9982-87.6877-37.4992-1.20 0 0-66.8089-38.2236-36.8414-66.8089QC'd by Pharmacopeia
Inhibitor35.481347.340560Complete curve; partial efficacy-4.454.95490.9906-107.1544-59.8139-1.20 0 0-87.9757-61.3159-58.1701-87.9757QC'd by Prestwick Chemical; Inc.
Inhibitor5.9508124.625145Partial curve; high efficacy-5.22542.72020.864-126.7319-2.1068-2.10 0 0 0 0 0 0 0 0 0 1000-13.748-1.3723-25.9483-11.282526.65188.4521-36.83-113.80310QC'd by ChemAxon
Inhibitor11.873489.544142Partial curve; partial efficacy-4.92541.24750.9863-91.1278-1.5837-2.20 0 0 0 0 1 0 0 0 0 0-74.7046000-4.6868-8.0974-38.15161.1319-8.2196-21.8072-47.3218-74.7046QC'd by Cayman
Inhibitor25.1189267.383841Partial curve; partial efficacy-4.64.95490.8835-100.7065166.6773-2.20 0 0-71.9482116.4983215.4265-71.9482QC'd by Tocris
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Cyclin-dependent kinase 2
External ID: CHEMBL5062802
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL301
ChEMBL Target Name: Cyclin-dependent kinase 2
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
Delta TM=0.1409CThermal Shift Assay
Delta TM=-0.01457CThermal Shift Assay
Delta TM=-0.19C
Delta TM=1.16CThermal Shift Assay
Delta TM=1.921CThermal Shift Assay
Delta TM=-0.3406CThermal Shift Assay
Delta TM=0.6CThermal Shift Assay
Delta TM=-0.1127CThermal Shift Assay
Delta TM=-1.169CThermal Shift Assay
Delta TM=0.82C
Delta TM=0.31CThermal Shift Assay
Delta TM=-0.02CThermal Shift Assay
Delta TM=0.46CThermal Shift Assay
Delta TM=-1.475CThermal Shift Assay
Delta TM=-0.6313CThermal Shift Assay
Delta TM=0CThermal Shift Assay
Delta TM=-0.6762CThermal Shift Assay
Delta TM=1.46CThermal Shift Assay
Delta TM=0.98CThermal Shift Assay
Delta TM=0.83CThermal Shift Assay
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844112
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard UnitsActivity Comment
Inhibition%Not Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844107
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
MRT=0.9hr
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844106
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
MRT=1hr
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School 靶标:N/A
External ID: HMS1315
Protocol: Cybrid cells were washed with PBS, trypsinized, spun down at 300g for 5 minutes, and resuspended in 10 mLs of PBS. Cells were counted, and the appropriate amount of cells were added to a vial containing DMEM (No Glucose) + 2%FBS + 1% P/S + 10mM Galactose, DMEM (No Glucose) + 2%FBS + 1% P/S + 10mM Galactose + 0.3% DMSO, DMEM No Glucose + 2% FBS + 1% P/S + 10mM Galactose + 1uM I-BET GSK 525762A, or DMEM (No Glucose) + 2%FBS + 1% P/S + 10mM Galactose + 1.25mM Glucose. Cells were then seeded in a Corning 3570 384-well plate (40 ul/well,1500 cells/well). Two replicates were prepared as described at the same time per library plate.

100 nl of compound was added to each well via pin transfer immediately after seeding. After the addition of compound, cells were incubated for 72 hours at 37 degrees C with 5% CO2.

Following the 72 hour incubation period, the 384 well plates were centrifuged for 1 minute at 1000 rpm. The media was aspirated using an aspiration wand and fresh media DMEM only, was added to the cells (40uL/ well) using a well-mate. Fifteen-microliters of Cell Titer Glow substrate was then added to each well using the well-mate. The plates were gently vortexed for 10 seconds and then centrifuged for 1 minute at 1000 rpm. The plates were then immediately read on the Envision instrument and the luminescence was detected for each individual well.

Positive control (strong): Cells seeded in DMEM (No Glucose) + 2%FBS + 1% P/S + 10mM Galactose + 1.25mM Glucose
Positive control (weak): Cells seeded in DMEM No Glucose + 2% FBS + 1% P/S + 10mM Galactose + 1uM I-BET GSK 525762A
Negative control: Cells seeded in DMEM (No Glucose) + 2%FBS + 1% P/S + 10mM Galactose + 0.3% DMSO
Comment: Data analysis method and criteria for scoring active compounds:

Z-scores were calculated for both replicates separately using the plate average and standard deviation of experimental well luminescence (Z = (x - mu)/sigma). Compounds were considered active if both replicate Z-scores >= 1.8. Activity scores were determined by scaling replicate average Z-scores from 0 (activity score = 0) to 4 (activity score = 100), with activity score > 45 being considered active. Z-scores < 0 were set to activity score = 0; Z-scores > 4 were set to activity score = 100 (100% activity).
Luminescence_ALuminescence_BZ-score Rep AZ-score Rep B
15087591941614-0.29-0.43
17411761927012-0.01-0.44
197614624877510.290.11
347045740451192.151.64
244929828664190.880.48
15633732388055-0.230.01
182721124299270.10.05
235000430356-1.88-1.91
15443152345114-0.25-0.03
182392827546700.10.37
10776522101177-0.83-0.27
190465327072880.20.33
327799138504031.911.45
16951292723755-0.060.34
401368547421142.822.33
245078133481490.880.96
253134330714220.980.69
229493728987220.680.52
16507292422255-0.120.05
12125591703208-0.66-0.66
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844105
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
MRT(t)=0.9hr
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844104
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
MRT(t)=0.9hr
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844110
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard Value
Ratio=1.622
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:23265 靶标:
External ID: IucA Pilot Assay Tocris Library
Protocol: A solution containing 55.6 mM HEPES pH 7.5, 0.11% Tween 20, 16.7 mM MgCl2, 55.6 mM hydroxylamine, 55.6 microM ATP, 55.6 microM citrate, and 0.28 U/mL IPP was dispensed (45 microL) into clear polystyrene microplates (Corning, Inc.) using a BioTek MicroFlo dispenser.

Next, 40 nL of test compounds (10 mM in DMSO, 8 microM final concentration) were transferred from deep-well blocks to the reaction solution using a stainless-steel pin tool operated by a robotic workstation (JANUS, PerkinElmer, Waltham, MA). The IucA-catalyzed reaction was initiated by adding 5 microL of 3 microM IucA in 25 mM HEPES, 75 mM NaCl, and 0.1 mM TCEP at pH 7.5.

The reactions were allowed to proceed for 30 min at room temperature before being quenched by dispensing (microFill, BioTek) 13 microL of MG developing solution, containing 1.0 mg/mL MG oxalate, 1.5% (w/v) ammonium molybdate, 0.15% (v/v) Tween 20, and 4.7 N sulfuric acid. After allowing the assay color to develop/stabilize for 30 min, the absorbance at 620 nm was measured (EnVision 2103 Multilabel Microplate Reader, PerkinElmer).

Average positive controls from 24 wells with no test compound and average negative controls from 8 wells with no enzyme were calculated. Dynamic range was calculated by difference between Avg Pos Control and Avg Neg Control. Percent inhibition was calculated by the ratio of (Avg. Pos. Ctrl - Sample OD) to Dynamic Range.
Comment: Protein Target is
IucA

EMB09144
574 aa
G057_19877
Klebsiella pneumoniae hvKP1

Active compounds were defined by <80% activity at 8 microM screening concentration.
OD%Activity384ID
0.98497.1319127496888TO1A04
1.004100.68831130342TO1A06
1.06110.646227253868TO1A07
1.023104.066889929465TO1A08
1.025104.422529784838TO1A09
1.032105.667269278644TO1A10
1.019103.355610218718TO1A11
1.059110.468407326181TO1A14
1.049108.690208049315TO1A15
1.044107.801108410883TO1A16
1.047108.334568193942TO1A17
1.054109.579307687748TO1A18
1.137124.338361685733TO1A19
1.109119.359403710509TO1A20
1.089115.803005156778TO1A21
1.097117.22556457827TO1A22
0.98998.0210123881216TO1B03
0.98296.7762728943157TO1B04
0.99298.5544721711813TO1B05
1.016102.822150435659TO1B06
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844109
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
Cp<1ng/ml
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844108
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
Ct<1ng/ml
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844099
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
AUC=484ng.hr.mL-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844098
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
AUC=737.8ng.hr.mL-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Casein kinase I isoform delta
External ID: CHEMBL5064320
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL2828
ChEMBL Target Name: Casein kinase I delta
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
Delta TM=1.5CThermal Shift Assay
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844097
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
AUC=481.7ng.hr.mL-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844096
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
T1/2=1.1hr
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:Broad Institute 靶标:N/A
External ID: 7124-01_Inhibitor_SinglePoint_HTS_Activity
Protocol:
Protocol:
1) Plate 10 uL BL2-NFkB-luc cells at 12.5K cells/well, using a Multidrop Combi reagent dispenser (1,250 cells/uL).
2) Add 25 nL compound or positive control, by pin transfer; IKK inhibitor VII will be used at 50 uM.
3) Incubate at 37 masculineC for 1 hour (allowing compounds to enter cells for action).
4) Add 5 uL 192 ng/mL tCD40L per well for a final concentration of 64 ng/ml using a Thermo Multidrop Combi.
5) Incubate at 37 masculineC for 4 hrs, then leave plate at RT for 30 minutes.
6) Add 15 uL SteadyGlo luciferase substrate (Promega) per well using a Thermo Multidrop Combi.
7) Incubate at RT for 5min, then read Luminescence using LJL Analyst HT plate reader.
Comment: PRESENCE OF CONTROLS: Neutral control wells (NC) and positive control wells (PC) were included on every plate.

EXPECTED OUTCOME: Active compounds result in decreasing readout signal.

NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls Minus Inhibitors' method in Genedata Assay Analyzer (v10.0.2):
The median raw signal of the intraplate neutral control wells was set to a normalized activity value of 0.
The median raw signal of the intraplate positive control wells was set to a normalized activity value of -100.
Experimental wells values were scaled to this range.

PATTERN CORRECTION: No plate pattern correction algorithm from Genedata Condoseo (v.10.0.2) was applied.

PUBCHEM_ACTIVITY_SCORE:
This was set as equal to the mean of the normalized sample replicate activities, rounded to the nearest integer .
The minimum PUBCHEM_ACTIVITY_SCORE required for a compound to be called a hit (the activity threshold, or AT) was set at -50.

PERCENTAGE OF ACTIVE REPLICATES:
For each sample, the percentage of replicates (PCT_ACTIVE_REP) which had activity scores >= AT was determined.
The minimum percentage of replicates required for a compound to be called a hit (PAR_T) was set at 55.

PUBCHEM_ACTIVITY_OUTCOME:
Samples passing BOTH threshold criteria were assigned an outcome of 2 (active):
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP >= PAR_T

Samples passing NEITHER threshold criteria were assigned an outcome of 1 (inactive):
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP < PAR_T

Samples passing AT only were assigned an outcome of 1 (inactive) :
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP < PAR_T

Samples passing PAR_T only were assigned an outcome of 1 (inactive) :
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP >= PAR_T
REPRODUCIBILITY_COSINE_TRANSFORMPCT_ACTIVE_REPLICATESREPLICATE_A_ACTIVITY_SCORE_10uM_(%)REPLICATE_B_ACTIVITY_SCORE_10uM_(%)REPLICATE_C_ACTIVITY_SCORE_10uM_(%)REPLICATE_D_ACTIVITY_SCORE_10uM_(%)REPLICATE_A_ACTIVITY_SCORE_25uM_(%)REPLICATE_B_ACTIVITY_SCORE_25uM_(%)
0.79620-2.349-0.32
105.6735.654
0.992109.2477.171
1010.26510.389
0.99270-11.538-9.04
004.22
0.988401.71.248
0.859020.4545.179
0.572505.367-0.953
0.980-5.16-7.79
0.95509.6865.096
0.68210-13.0050.453
0.875408.3542.409
0.9468011.7385.785
0.98530-15.255-10.751
0.5260-1.7597.464
0.84350102.218
0.9897019.1614.325
10-28.597-28.833
0.993506.7018.436
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844103
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
CL=35mL.min-1.kg-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:Broad Institute 靶标:histone-lysine N-methyltransferase EZH2 isoform a [Homo sapiens]
External ID: 2125-01_Inhibitor_SinglePoint_HTS_Activity
Protocol: Protocol:
PRC2 activity was measured using Dissociation-Enhanced Lanthanide Fluoro-ImmunoAssays (DELFIA) performed on 384-well, white, streptavidin-coated plates (PerkinElmer). In short, PRC2 was diluted to 30 ng and 3 ng per well in 20 uL 2X Enzyme Buffer (50mM Tris HCl pH 8.5, 10 mM DTT, 5 mM MgCl). Compounds were pinned at 100 nL per well and reactions were initiated with 20 uL of a 5 uM SAM (NEB) solution containing 600 nM H3[21-44]-GK-biotin (AnaSpec; PRC2).

Plates were incubated at room temperature for 1 hr and then washed three times with 100 uL of Wash Buffer (50mM Tris pH 7.4, 150 mM NaCl, 0.05% Tween 20, 0.2% BSA). 50 ul of Fluoroimmunoassay (FI) Buffer (50 mM Tris HCl pH 7.8, 150 mM NaCl, 0.05% Tween 40, 25 iM DTPA, 0.2% BSA, 0.05% BGG)containing a 1:4000 dilution of anti-H3K27me2 rabbit IgG (Cell Signaling, #9728) with 691 ng/mL Eu-N1-anti-rabbit IgG (PerkinElmer)was added to each well for PRC2 reactions.

Following 1 hr incubation at room temperature, the plates were washed three times with Wash Buffer and 50 uL of Enhancement Solution (PerkinElmer) was added to each well. Plates were incubated for 30 min at room temperature and time-resolved fluorescence (TRF) was measured on Wallac Envision 2104 Multilabel Reader (400 us window, 400 us delay, 320 excitation, 615 emission).
Comment: PRESENCE OF CONTROLS: Neutral control wells (NC) and positive control wells (PC) were included on every plate.

EXPECTED OUTCOME: Active compounds result in decreasing readout signal.

NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls Minus Inhibitors' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral control wells was set to a normalized activity value of 0.
The median raw signal of the intraplate positive control wells was set to a normalized activity value of -100.
Experimental wells values were scaled to this range.
All well activities were then multiplied by -1 to create a positive activity readout value range, to match Pubchem convention.

PATTERN CORRECTION: No plate pattern correction algorithm from Genedata Condoseo (v.7.0.3) was applied.

PUBCHEM_ACTIVITY_SCORE:
This was set as equal to the mean of the normalized sample replicate activities, rounded to the nearest integer .
The minimum PUBCHEM_ACTIVITY_SCORE required for a compound to be called a hit (the activity threshold, or AT) was set at 50.

PERCENTAGE OF ACTIVE REPLICATES:
For each sample, the percentage of replicates (PCT_ACTIVE_REP) which had activity scores >= AT was determined.
The minimum percentage of replicates required for a compound to be called a hit (PAR_T) was set at 100.

PUBCHEM_ACTIVITY_OUTCOME:
Samples passing BOTH threshold criteria were assigned an outcome of 2 (active):
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP >= PAR_T

Samples passing NEITHER threshold criteria were assigned an outcome of 1 (inactive):
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP < PAR_T

Samples passing AT only were assigned an outcome of 3 (inconclusive) :
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP < PAR_T

Samples passing PAR_T only were assigned an outcome of 1 (inactive) :
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP >= PAR_T
REPRODUCIBILITY_COSINE_TRANSFORMPCT_ACTIVE_REPLICATESREPLICATE_A_ACTIVITY_SCORE_12.5uM_(%)REPLICATE_B_ACTIVITY_SCORE_12.5uM_(%)
000.193
00-0.443
000.02
00-10.883
003.986
0016.236
0038.043
003.387
0013.272
00-0.209
000.757
002.786
00-12.234
00-10.048
001.844
00-2.259
00-8.602
001.219
006.005
0013.086
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:HEK-293T
External ID: CHEMBL5058565
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL3706568
ChEMBL Target Name: HEK-293T
ChEMBL Target Type: CELL-LINE - Target is a specific cell-line
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueActivity Comment
Cell Viability=0.95Growth Rate
Cell Viability=1.34Growth Rate
Cell Viability=1Growth Rate
Cell Viability=0.78Growth Rate
Cell Viability=0.82Growth Rate
Cell Viability=0.68Growth Rate
Cell Viability=1.62Growth Rate
Cell Viability=1.39Growth Rate
Cell Viability=1.18Growth Rate
Cell Viability=1.25Growth Rate
Cell Viability=0.6Growth Rate
Cell Viability=1.86Growth Rate
Cell Viability=1.28Growth Rate
Cell Viability=1.23Growth Rate
Cell Viability=1.1Growth Rate
Cell Viability=1.67Growth Rate
Cell Viability=0.76Growth Rate
Cell Viability=0.77Growth Rate
Cell Viability=0.97Growth Rate
Cell Viability=0.88Growth Rate
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844102
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
CL=23.33mL.min-1.kg-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844101
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
Vd=3.1L.kg-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School 靶标:N/A
External ID: HMS1482
Protocol: Prior to screening, cells were passaged in high glucose DMEM supplemented with 10% FBS, 1% P/S, 1 mM pyruvate, and HEPES. Media was changed every 1-2 days to prevent starvation and maintain cellular health.

On the day of screening, 384-well plates (Corning 3765) were filled with 30 uL of control cybrid cell suspension (33.3 cells/ul). Media for resuspension was DMEM supplemented with 10% FBS, 1% P/S, 1 mM pyruvate, and HEPES. Positive control columns were 23 and 24 for most plate setups. Initially, tunicamycin (15 nM) and galactose media (10 mM + 1 mM glucosamine) were used in columns 23 and 24, respectively. Over the course of the screen, galactose was substituted with Vidofludimus (11 uM). Next, 33 nL of each compound were pin-transferred to each plate in duplicate. Final assay well volume was 30 uL. Plates were stacked 2 high, covered with lids, and incubated at 37 degrees C for 2 days.

After 2 days of incubation, Hoescht (10 ul/well) was added to assay plates and fluorescence was read using the Acumen laser scanning cytometer. After, the bottom of plates were sealed with two layers of Brightmax Sealing Films. Then Promega NanoGlo Live cell reagent (20 ul/well) was added to each well and luminescence was read on a PerkinElmer EnVision plate reader after 5 minute of shaking.
Comment: Data analysis method and criteria for scoring active compounds:

Normalized luminescence values (luminescence / cell number) for each replicate were calculated (based on average of 2 luminescence reads per replicate). Z-scores were calculated using the plate average and standard deviation of experimental well normalized values. Each plate replicate was individually analyzed to measure reproducibility across plates. Z-scores were then averaged across replicates and a Z-score threshold of 1.96 was selected for positive hits, indicating increased mitochondrial supercomplex formation. Wells were excluded from further consideration based on low cell number (1 or both replicates with number of objects count < 1500). Activity scores were determined by scaling Z-scores from 0 (activity score = 0) to 4 (activity score = 100), with activity score > 50 being considered active. Z-scores < 0 were set to activity score = 0; Z-scores > 4 were set to activity score = 100 (100% activity).
Luminescence_R1_ALuminescence_R2_AHoechst_NumObjects_ALuminescence_R1_BLuminescence_R2_BHoechst_NumObjects_BAvgLumin_ARatio_AAvgLumin_BRatio_BHoescht_AvgRatio_Z scoreCommentMolar Concentration
3005832966014427396274381039475429859267.447938865681.75364590.5-0.5094812 mM
3063983015303313363462354883342330396491.7489359172104.92933680.28240710 mM
3229973242934706384126370237418532364568.772837718290.1274445.5-0.3493792 mM
2814872771794410298737291541441927933363.340829513966.78864414.5-0.82501210 mM
3319403273095409320983313490473232962460.9431723667.04075070.5-0.8614472 mM
101988101433913127273124739927101710111.403126006135.929cell number censor10 mM
12229312250110001354451298281047122397122.397132636126.682cell number censor2 mM
31668831269918422981712925611315314694170.843295366224.613cell number censor10 mM
2586182572734710308202299107470525794654.765530365464.53874707.5-1.006962 mM
7032470701868774087427981170512.581.235675843.593.5185cell number censor10 mM
735767286684281944781318307322186.960880037.596.4307cell number censor2 mM
138603137684180161874155778147138144767.4641588261080.45cell number censor10 mM
3688123655174887445802425830475136716475.130943581691.73144819-0.2155272 mM
3598523457175201364558356321414235278467.830136044087.02064671.5-0.416410 mM
3539193476365169378702373151513035077867.861837592673.285149.5-0.6418412 mM
2634832564394783312776297786467925996154.35130528165.24494731-1.0023510 mM
6959871606920864718552210267060276.741385996.583.8173cell number censor2 mM
3588413473594602354858348321495635310076.727535159070.94224779-0.530435400 uM
3545733465325377378990366658522935055265.194837282471.29935303-0.71949480 uM
3160983101214700323640306279439731311066.61931496071.63054548.5-0.689973400 uM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4844100
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775
Standard TypeStandard RelationStandard ValueStandard Units
Vd=2.1L.kg-1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Sphingosine 1-phosphate receptor 2
External ID: CHEMBL4844091
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775

Target ChEMBL ID: CHEMBL2955
ChEMBL Target Name: Sphingosine 1-phosphate receptor Edg-5
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned
Standard TypeStandard RelationStandard ValueStandard Units
Activity=4.87mg/L
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Glycogen synthase kinase-3 beta
External ID: CHEMBL5065589
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL262
ChEMBL Target Name: Glycogen synthase kinase-3 beta
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
Delta TM=5.443CThermal Shift Assay
Delta TM=-0.3085CThermal Shift Assay
Delta TM=-0.7C
Delta TM=-0.03CThermal Shift Assay
Delta TM=11.17CThermal Shift Assay
Delta TM=-1.553CThermal Shift Assay
Delta TM=-0.29CThermal Shift Assay
Delta TM=-0.3615CThermal Shift Assay
Delta TM=0.0664CThermal Shift Assay
Delta TM=-0.66C
Delta TM=-0.06CThermal Shift Assay
Delta TM=-0.21CThermal Shift Assay
Delta TM=-0.26CThermal Shift Assay
Delta TM=-1.145CThermal Shift Assay
Delta TM=-0.6697CThermal Shift Assay
Delta TM=0CThermal Shift Assay
Delta TM=-0.4876CThermal Shift Assay
Delta TM=2.74CThermal Shift Assay
Delta TM=0.22CThermal Shift Assay
Delta TM=-0.06CThermal Shift Assay
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Sphingosine 1-phosphate receptor 2
External ID: CHEMBL4844092
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2021
Volume: 225
First Page: 113775
Last Page: 113775
DOI: 10.1016/j.ejmech.2021.113775

Target ChEMBL ID: CHEMBL2955
ChEMBL Target Name: Sphingosine 1-phosphate receptor Edg-5
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned
Standard TypeStandard RelationStandard ValueStandard Units
Activity=1.37mg/L
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Tyrosine-protein kinase ABL1
External ID: CHEMBL5060015
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL1862
ChEMBL Target Name: Tyrosine-protein kinase ABL
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
Delta TM=2.866CThermal Shift Assay
Delta TM=-0.1161CThermal Shift Assay
Delta TM=0.32C
Delta TM=0.12CThermal Shift Assay
Delta TM=1.321CThermal Shift Assay
Delta TM=-0.3289CThermal Shift Assay
Delta TM=0.97CThermal Shift Assay
Delta TM=-0.00477CThermal Shift Assay
Delta TM=0.8545CThermal Shift Assay
Delta TM=0.25C
Delta TM=0.05CThermal Shift Assay
Delta TM=0.01CThermal Shift Assay
Delta TM=0.57CThermal Shift Assay
Delta TM=-0.2514CThermal Shift Assay
Delta TM=-0.09405CThermal Shift Assay
Delta TM=0.1211CThermal Shift Assay
Delta TM=0.2152CThermal Shift Assay
Delta TM=4.95CThermal Shift Assay
Delta TM=0.78CThermal Shift Assay
Delta TM=0.49CThermal Shift Assay
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N-formyl peptide receptor 2
External ID: CHEMBL5209827
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4227
ChEMBL Target Name: Lipoxin A4 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=-20.21%Antagonist %Inhib (Mean)
%Inhib (Mean)=3.62%Antagonist %Inhib (Mean)
%Inhib (Mean)=-14.95%Antagonist %Inhib (Mean)
%Inhib (Mean)=-22.09%Antagonist %Inhib (Mean)
%Inhib (Mean)=-22.7%Antagonist %Inhib (Mean)
%Inhib (Mean)=-11.32%Antagonist %Inhib (Mean)
%Inhib (Mean)=-16.76%Antagonist %Inhib (Mean)
%Inhib (Mean)=-17.93%Antagonist %Inhib (Mean)
%Max (Mean)=-1.8%Agonist %Max (Mean)
%Inhib (Mean)=-18.34%Antagonist %Inhib (Mean)
%Inhib (Mean)=-13.22%Antagonist %Inhib (Mean)
%Inhib (Mean)=-7.81%Antagonist %Inhib (Mean)
%Inhib (Mean)=-14.04%Antagonist %Inhib (Mean)
%Inhib (Mean)=-8.49%Antagonist %Inhib (Mean)
%Max (Mean)=-2.33%Agonist %Max (Mean)
%Inhib (Mean)=-8.67%Antagonist %Inhib (Mean)
%Max (Mean)=-2.13%Agonist %Max (Mean)
%Inhib (Mean)=-9.58%Antagonist %Inhib (Mean)
%Inhib (Mean)=3.94%Antagonist %Inhib (Mean)
%Inhib (Mean)=-19.94%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N-formyl peptide receptor 2
External ID: CHEMBL5209826
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4227
ChEMBL Target Name: Lipoxin A4 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=20.59%Antagonist %Inhib (Mean)
%Max (Mean)=-3.14%Agonist %Max (Mean)
%Inhib (Mean)=14.37%Antagonist %Inhib (Mean)
%Max (Mean)=-3.69%Agonist %Max (Mean)
%Inhib (Mean)=-16.6%Antagonist %Inhib (Mean)
%Max (Mean)=-2.48%Agonist %Max (Mean)
%Max (Mean)=1.81%Agonist %Max (Mean)
%Inhib (Mean)=-36.4%Antagonist %Inhib (Mean)
%Inhib (Mean)=-6.18%Antagonist %Inhib (Mean)
%Max (Mean)=-3.47%Agonist %Max (Mean)
%Inhib (Mean)=18.01%Antagonist %Inhib (Mean)
%Max (Mean)=-2.849%Agonist %Max (Mean)
%Inhib (Mean)=-28.76%Antagonist %Inhib (Mean)
%Max (Mean)=-2.95%Agonist %Max (Mean)
%Inhib (Mean)=-2.24%Antagonist %Inhib (Mean)
%Inhib (Mean)=61.06%Antagonist %Inhib (Mean)
%Max (Mean)=-2.41%Agonist %Max (Mean)
%Inhib (Mean)=35.08%Antagonist %Inhib (Mean)
%Max (Mean)=-1.569%Agonist %Max (Mean)
%Inhib (Mean)=-26.45%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Glucagon-like peptide 1 receptor
External ID: CHEMBL5209829
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL1784
ChEMBL Target Name: Glucagon-like peptide 1 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Max (Mean)=-0.52%Agonist %Max (Mean)
%Inhib (Mean)=1.9%Antagonist %Inhib (Mean)
%Inhib (Mean)=46.53%Antagonist %Inhib (Mean)
%Max (Mean)=0.81%Agonist %Max (Mean)
%Max (Mean)=0%Agonist %Max (Mean)
%Inhib (Mean)=-17.37%Antagonist %Inhib (Mean)
%Max (Mean)=-0.31%Agonist %Max (Mean)
%Inhib (Mean)=-42.05%Antagonist %Inhib (Mean)
%Inhib (Mean)=-9.7%Antagonist %Inhib (Mean)
%Max (Mean)=0.12%Agonist %Max (Mean)
%Inhib (Mean)=-9.08%Antagonist %Inhib (Mean)
%Max (Mean)=-3.168%Agonist %Max (Mean)
%Inhib (Mean)=-39.97%Antagonist %Inhib (Mean)
%Max (Mean)=-0.14%Agonist %Max (Mean)
%Inhib (Mean)=-34.58%Antagonist %Inhib (Mean)
%Inhib (Mean)=56.23%Antagonist %Inhib (Mean)
%Max (Mean)=0%Agonist %Max (Mean)
%Inhib (Mean)=66.71%Antagonist %Inhib (Mean)
%Max (Mean)=-0.9215%Agonist %Max (Mean)
%Inhib (Mean)=-18.07%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N-formyl peptide receptor 2
External ID: CHEMBL5209828
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4227
ChEMBL Target Name: Lipoxin A4 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=16.28%Antagonist %Inhib (Mean)
%Max (Mean)=-2.42%Agonist %Max (Mean)
%Inhib (Mean)=-16.1%Antagonist %Inhib (Mean)
%Inhib (Mean)=19.8%Antagonist %Inhib (Mean)
%Inhib (Mean)=-24.57%Antagonist %Inhib (Mean)
%Inhib (Mean)=-23.23%Antagonist %Inhib (Mean)
%Inhib (Mean)=-1.69%Antagonist %Inhib (Mean)
%Max (Mean)=-2.48%Agonist %Max (Mean)
%Inhib (Mean)=15.7%Antagonist %Inhib (Mean)
%Inhib (Mean)=-10.42%Antagonist %Inhib (Mean)
%Inhib (Mean)=-17.87%Antagonist %Inhib (Mean)
%Inhib (Mean)=0.37%Antagonist %Inhib (Mean)
%Inhib (Mean)=-12.52%Antagonist %Inhib (Mean)
%Max (Mean)=-1.87%Agonist %Max (Mean)
%Inhib (Mean)=-7.05%Antagonist %Inhib (Mean)
%Inhib (Mean)=-4%Antagonist %Inhib (Mean)
%Inhib (Mean)=-13.72%Antagonist %Inhib (Mean)
%Inhib (Mean)=-1.16%Antagonist %Inhib (Mean)
%Inhib (Mean)=-35.15%Antagonist %Inhib (Mean)
%Inhib (Mean)=-9.1%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Free fatty acid receptor 4
External ID: CHEMBL5209823
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL5339
ChEMBL Target Name: G-protein coupled receptor 120
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Max (Mean)=-1.859%Agonist %Max (Mean)
%Inhib (Mean)=-35.14%Antagonist %Inhib (Mean)
%Max (Mean)=0%Agonist %Max (Mean)
%Inhib (Mean)=-32.8%Antagonist %Inhib (Mean)
%Inhib (Mean)=-32.11%Antagonist %Inhib (Mean)
%Max (Mean)=-1.3%Agonist %Max (Mean)
%Inhib (Mean)=-53.6%Antagonist %Inhib (Mean)
%Max (Mean)=-0.4171%Agonist %Max (Mean)
%Inhib (Mean)=-68.27%Antagonist %Inhib (Mean)
%Max (Mean)=-3.637%Agonist %Max (Mean)
%Inhib (Mean)=-35.64%Antagonist %Inhib (Mean)
%Max (Mean)=1.5%Agonist %Max (Mean)
%Inhib (Mean)=-347.9%Antagonist %Inhib (Mean)
%Inhib (Mean)=-179.97%Antagonist %Inhib (Mean)
%Max (Mean)=-6.66%Agonist %Max (Mean)
%Inhib (Mean)=69.11%Antagonist %Inhib (Mean)
%Inhib (Mean)=-41.58%Antagonist %Inhib (Mean)
%Max (Mean)=-1.8%Agonist %Max (Mean)
%Inhib (Mean)=0.7%Antagonist %Inhib (Mean)
%Inhib (Mean)=29.29%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:HCT-116
External ID: CHEMBL5121095
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Eur J Med Chem
Year: 2022
Volume: 227
First Page: 113923
Last Page: 113923
DOI: 10.1016/j.ejmech.2021.113923

Target ChEMBL ID: CHEMBL394
ChEMBL Target Name: HCT-116
ChEMBL Target Type: CELL-LINE - Target is a specific cell-line
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard Units
45.31EC50=45310nM
36.54EC50=36540nM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:CX3C chemokine receptor 1
External ID: CHEMBL5209822
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4843
ChEMBL Target Name: C-X3-C chemokine receptor 1
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=13.92%Antagonist %Inhib (Mean)
%Max (Mean)=-2.71%Agonist %Max (Mean)
%Inhib (Mean)=-35.49%Antagonist %Inhib (Mean)
%Inhib (Mean)=19%Antagonist %Inhib (Mean)
%Inhib (Mean)=-45.53%Antagonist %Inhib (Mean)
%Inhib (Mean)=-48.22%Antagonist %Inhib (Mean)
%Inhib (Mean)=-17.88%Antagonist %Inhib (Mean)
%Inhib (Mean)=10.69%Antagonist %Inhib (Mean)
%Max (Mean)=-2.05%Agonist %Max (Mean)
%Inhib (Mean)=-39.01%Antagonist %Inhib (Mean)
%Inhib (Mean)=-31.99%Antagonist %Inhib (Mean)
%Inhib (Mean)=-15.91%Antagonist %Inhib (Mean)
%Inhib (Mean)=-17.23%Antagonist %Inhib (Mean)
%Max (Mean)=-2.32%Agonist %Max (Mean)
%Inhib (Mean)=-29.38%Antagonist %Inhib (Mean)
%Inhib (Mean)=-13.4%Antagonist %Inhib (Mean)
%Inhib (Mean)=-14.36%Antagonist %Inhib (Mean)
%Inhib (Mean)=-12.75%Antagonist %Inhib (Mean)
%Inhib (Mean)=-25.22%Antagonist %Inhib (Mean)
%Inhib (Mean)=-23.27%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:SW620/5-FU
External ID: CHEMBL5121096
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Eur J Med Chem
Year: 2022
Volume: 227
First Page: 113923
Last Page: 113923
DOI: 10.1016/j.ejmech.2021.113923

Target ChEMBL ID: CHEMBL5209888
ChEMBL Target Name: SW620/5-FU
ChEMBL Target Type: CELL-LINE - Target is a specific cell-line
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard Units
39.23EC50=39230nM
39.21EC50=39210nM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Free fatty acid receptor 4
External ID: CHEMBL5209825
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL5339
ChEMBL Target Name: G-protein coupled receptor 120
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=33.36%Antagonist %Inhib (Mean)
%Max (Mean)=-2.5%Agonist %Max (Mean)
%Inhib (Mean)=-14.49%Antagonist %Inhib (Mean)
%Inhib (Mean)=7.5%Antagonist %Inhib (Mean)
%Inhib (Mean)=-56.39%Antagonist %Inhib (Mean)
%Inhib (Mean)=-33.16%Antagonist %Inhib (Mean)
%Inhib (Mean)=-42.68%Antagonist %Inhib (Mean)
%Max (Mean)=-2.27%Agonist %Max (Mean)
%Inhib (Mean)=25.37%Antagonist %Inhib (Mean)
%Inhib (Mean)=-17.49%Antagonist %Inhib (Mean)
%Inhib (Mean)=-28.86%Antagonist %Inhib (Mean)
%Inhib (Mean)=-17.91%Antagonist %Inhib (Mean)
%Inhib (Mean)=-20.58%Antagonist %Inhib (Mean)
%Max (Mean)=-1.92%Agonist %Max (Mean)
%Inhib (Mean)=-47.99%Antagonist %Inhib (Mean)
%Inhib (Mean)=-19.17%Antagonist %Inhib (Mean)
%Inhib (Mean)=-46.36%Antagonist %Inhib (Mean)
%Inhib (Mean)=-38.26%Antagonist %Inhib (Mean)
%Inhib (Mean)=-10.82%Antagonist %Inhib (Mean)
%Inhib (Mean)=-48.57%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Free fatty acid receptor 4
External ID: CHEMBL5209824
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL5339
ChEMBL Target Name: G-protein coupled receptor 120
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=31.47%Antagonist %Inhib (Mean)
%Max (Mean)=-2.56%Agonist %Max (Mean)
%Inhib (Mean)=-29.67%Antagonist %Inhib (Mean)
%Inhib (Mean)=12.95%Antagonist %Inhib (Mean)
%Inhib (Mean)=-107.59%Antagonist %Inhib (Mean)
%Inhib (Mean)=-36.71%Antagonist %Inhib (Mean)
%Inhib (Mean)=-76.49%Antagonist %Inhib (Mean)
%Max (Mean)=-2.11%Agonist %Max (Mean)
%Inhib (Mean)=-29.81%Antagonist %Inhib (Mean)
%Inhib (Mean)=-71.31%Antagonist %Inhib (Mean)
%Inhib (Mean)=-40.25%Antagonist %Inhib (Mean)
%Inhib (Mean)=-24.55%Antagonist %Inhib (Mean)
%Inhib (Mean)=-89.15%Antagonist %Inhib (Mean)
%Max (Mean)=-2.52%Agonist %Max (Mean)
%Inhib (Mean)=-36.82%Antagonist %Inhib (Mean)
%Inhib (Mean)=-15.9%Antagonist %Inhib (Mean)
%Inhib (Mean)=-16.38%Antagonist %Inhib (Mean)
%Inhib (Mean)=-96.32%Antagonist %Inhib (Mean)
%Inhib (Mean)=-4.38%Antagonist %Inhib (Mean)
%Inhib (Mean)=-36.79%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:C5a anaphylatoxin chemotactic receptor 1
External ID: CHEMBL5209819
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL2373
ChEMBL Target Name: C5a anaphylatoxin chemotactic receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=18.71%Antagonist %Inhib (Mean)
%Max (Mean)=-1.92%Agonist %Max (Mean)
%Inhib (Mean)=-17.38%Antagonist %Inhib (Mean)
%Inhib (Mean)=24.62%Antagonist %Inhib (Mean)
%Inhib (Mean)=-13.76%Antagonist %Inhib (Mean)
%Inhib (Mean)=-29.92%Antagonist %Inhib (Mean)
%Inhib (Mean)=6.06%Antagonist %Inhib (Mean)
%Max (Mean)=-2.12%Agonist %Max (Mean)
%Inhib (Mean)=15.42%Antagonist %Inhib (Mean)
%Inhib (Mean)=-18.71%Antagonist %Inhib (Mean)
%Inhib (Mean)=-34.45%Antagonist %Inhib (Mean)
%Inhib (Mean)=-0.18%Antagonist %Inhib (Mean)
%Inhib (Mean)=-3.96%Antagonist %Inhib (Mean)
%Max (Mean)=-2.11%Agonist %Max (Mean)
%Inhib (Mean)=-13.55%Antagonist %Inhib (Mean)
%Inhib (Mean)=-3.45%Antagonist %Inhib (Mean)
%Inhib (Mean)=7.41%Antagonist %Inhib (Mean)
%Inhib (Mean)=-6.72%Antagonist %Inhib (Mean)
%Inhib (Mean)=-36.6%Antagonist %Inhib (Mean)
%Inhib (Mean)=-0.28%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:C5a anaphylatoxin chemotactic receptor 1
External ID: CHEMBL5209818
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL2373
ChEMBL Target Name: C5a anaphylatoxin chemotactic receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=17.78%Antagonist %Inhib (Mean)
%Max (Mean)=-2.1%Agonist %Max (Mean)
%Inhib (Mean)=-21.66%Antagonist %Inhib (Mean)
%Inhib (Mean)=25.66%Antagonist %Inhib (Mean)
%Inhib (Mean)=-33.67%Antagonist %Inhib (Mean)
%Inhib (Mean)=-9.89%Antagonist %Inhib (Mean)
%Inhib (Mean)=-15.47%Antagonist %Inhib (Mean)
%Max (Mean)=-2.1%Agonist %Max (Mean)
%Inhib (Mean)=17.35%Antagonist %Inhib (Mean)
%Inhib (Mean)=-19.64%Antagonist %Inhib (Mean)
%Inhib (Mean)=-38.99%Antagonist %Inhib (Mean)
%Inhib (Mean)=-2.34%Antagonist %Inhib (Mean)
%Inhib (Mean)=-6.54%Antagonist %Inhib (Mean)
%Max (Mean)=-1.97%Agonist %Max (Mean)
%Inhib (Mean)=6.46%Antagonist %Inhib (Mean)
%Inhib (Mean)=-1.02%Antagonist %Inhib (Mean)
%Inhib (Mean)=9.44%Antagonist %Inhib (Mean)
%Inhib (Mean)=13.77%Antagonist %Inhib (Mean)
%Inhib (Mean)=-23.27%Antagonist %Inhib (Mean)
%Inhib (Mean)=-10.4%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Severe acute respiratory syndrome coronavirus 2
External ID: CHEMBL4303806
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Target ChEMBL ID: CHEMBL4303835
ChEMBL Target Name: SARS-CoV-2
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: SARS-CoV-2 Screening Data
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
18.92IC50=18920nM18.92 ± 0.39
19.11IC50=19110nM19.11 ± 0.47
1.65IC50=1650nM1.65 ± 0.54
4.71IC50=4710nM4.71 ± 2.41
2.76IC50=2760nM2.76 ± 1.3
5.68IC50=5680nM5.68 ± 0.04
0.2IC50=200nM0.2 ± 0.01
15.13IC50=15130nM15.13 ± 7.45
0.73IC50=730nM0.73 ± 0.1
18.27IC50=18270nM18.27 ± 0.18
0.64IC50=640nM0.64 ± 0.14
17.39IC50=17390nM17.39 ± 0.16
1.85IC50=1850nM1.85 ± 1.08
0.09IC50=90nM0.09 ± 0.02
3.93IC50=3930nM3.93 ± 1.76
1.89IC50=1890nM1.89 ± 0.03
14.97IC50=14970nM14.97 ± 6.7
1.61IC50=1610nM1.61 ± 0.4
18.59IC50=18590nM18.59 ± 0.09
5.91IC50=5910nM5.91 ± 0.57
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:CX3C chemokine receptor 1
External ID: CHEMBL5209821
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4843
ChEMBL Target Name: C-X3-C chemokine receptor 1
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=39.27%Antagonist %Inhib (Mean)
%Max (Mean)=-2.41%Agonist %Max (Mean)
%Inhib (Mean)=-49.25%Antagonist %Inhib (Mean)
%Inhib (Mean)=38.17%Antagonist %Inhib (Mean)
%Inhib (Mean)=-39.66%Antagonist %Inhib (Mean)
%Inhib (Mean)=-10.09%Antagonist %Inhib (Mean)
%Inhib (Mean)=-36.34%Antagonist %Inhib (Mean)
%Inhib (Mean)=4.47%Antagonist %Inhib (Mean)
%Max (Mean)=-2.93%Agonist %Max (Mean)
%Inhib (Mean)=-32.17%Antagonist %Inhib (Mean)
%Inhib (Mean)=-18.91%Antagonist %Inhib (Mean)
%Inhib (Mean)=-6.14%Antagonist %Inhib (Mean)
%Inhib (Mean)=-27.42%Antagonist %Inhib (Mean)
%Max (Mean)=-2.33%Agonist %Max (Mean)
%Inhib (Mean)=-24.55%Antagonist %Inhib (Mean)
%Inhib (Mean)=-8.39%Antagonist %Inhib (Mean)
%Inhib (Mean)=21.33%Antagonist %Inhib (Mean)
%Inhib (Mean)=-19.62%Antagonist %Inhib (Mean)
%Inhib (Mean)=-32.04%Antagonist %Inhib (Mean)
%Inhib (Mean)=-8.57%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:DNA polymerase kappa [Homo sapiens]
External ID: PolK100
Protocol: Three microliters of reagents (buffer in column 3 and 4 as negative control and 10 nM Pol kappa in columns 1, 2, and 5-48) were dispensed into a 1536-well black solid-bottom plate. Compounds (23 nL) were transferred via Kalypsys pin tool equipped with 1536-pin array. The plates were then incubated for 15 min at room temperature, and 1 uL substrate (50 nM final concentration) were then added to start the reaction and kinetically read twice at 0 min and 10 min on the Viewlux reader
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
PhenotypePotencyEfficacyAnalysis CommentCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0003270000 uMActivity at 0.0007732774 uMActivity at 0.00163 uMActivity at 0.00369 uMActivity at 0.00818 uMActivity at 0.020 uMActivity at 0.030 uMActivity at 0.047 uMActivity at 0.101 uMActivity at 0.151 uMActivity at 0.243 uMActivity at 0.477 uMActivity at 0.759 uMActivity at 1.287 uMActivity at 2.393 uMActivity at 3.818 uMActivity at 6.336 uMActivity at 11.99 uMActivity at 19.37 uMActivity at 31.37 uMActivity at 60.11 uMActivity at 107.2 uMActivity at 158.4 uMActivity at 229.0 uMCompound QC
Inactive40 0 0 0 01.4694-3.5669-6.2352.85861.80421.4694QC'd by "Chem Div"
Inactive40 0 0 0 0-4.26318.22188.081110.2927-3.9947-4.2631QC'd by "Chem Div"
Inactive40 0 0 0 06.03690.3398-2.1048-8.1695-3.68226.0369QC'd by "Chem Div"
Inactive4-2.05651.7294-3.5894-1.2575-0.5402-2.0565QC'd by "Chem Div"
Inactive40 0 0 0 12.31491.00484.6369-1.9963-3.35432.3149QC'd by "Chem Div"
Inactive47.27487.15156.13721.51975.23327.2748QC'd by "Chem Div"
Inactive40 0 0 0 01.006-3.3873-7.786-9.3037-9.17611.006QC'd by "Chem Div"
Inactive40 0 0 0 0-0.0368-9.4458-10.5155-9.0065-12.9141-0.0368QC'd by "Chem Div"
Inactive40 0 0 0 02.6-7.8084-12.3007-2.0954-6.68872.6QC'd by "Chem Div"
Inactive40 0 0 0 0-11.4867-18.9051-17.4955-19.0735-9.6682-11.4867QC'd by "Chem Div"
Inactive40 0 0 0 0-7.5605-17.2173-11.0038-16.5656-22.4025-7.5605QC'd by "Chem Div"
Inactive4-7.5451-1.1939-1.3084-5.8268-5.3206-7.5451QC'd by "Chem Div"
Inactive40 0 0 0 1-5.5852-4.3753-1.0046-3.1641-10.1524-5.5852QC'd by "Chem Div"
Inactive40 0 0 0 01.1172-6.03917.01189.04461.65331.1172QC'd by "Chem Div"
Inactive42.33591.25181.6626-0.9325-0.91942.3359QC'd by "Chem Div"
Inactive40 0 0 0-19.53540.3984-4.11472.1883-19.5354QC'd by "Chem Div"
Inactive4-5.6552-4.6769-1.9378-0.5867-3.224-5.6552QC'd by "Chem Div"
Inactive4-11.3738-10.4148-13.8912-10.4252-7.8961-11.3738QC'd by "Chem Div"
Inactive4-6.1571-8.7102-2.9113-5.2229-3.4369-6.1571QC'd by "Chem Div"
Inactive40 0 0 0 1-7.3803-8.8177-11.1654-6.5301-15.9483-7.3803QC'd by "Chem Div"
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Severe acute respiratory syndrome coronavirus 2
External ID: CHEMBL4303805
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4303835
ChEMBL Target Name: SARS-CoV-2
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: SARS-CoV-2 Screening Data
Standard TypeStandard RelationStandard ValueStandard UnitsData Validity Comment
Inhibition=-11.52%Outside typical range
Inhibition=5.09%
Inhibition=-1.71%
Inhibition=3.69%
Inhibition=22.47%
Inhibition=8.51%
Inhibition=-6.86%
Inhibition=-6.18%
Inhibition=-2.07%
Inhibition=3.91%
Inhibition=-5.9%
Inhibition=-2.45%
Inhibition=-5.55%
Inhibition=6.31%
Inhibition=-1.08%
Inhibition=12.7%
Inhibition=0.37%
Inhibition=8.88%
Inhibition=11.63%
Inhibition=-1.96%
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:CX3C chemokine receptor 1
External ID: CHEMBL5209820
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4843
ChEMBL Target Name: C-X3-C chemokine receptor 1
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Max (Mean)=-1.649%Agonist %Max (Mean)
%Inhib (Mean)=64.96%Antagonist %Inhib (Mean)
%Inhib (Mean)=51.4%Antagonist %Inhib (Mean)
%Max (Mean)=0.1251%Agonist %Max (Mean)
%Inhib (Mean)=-25.26%Antagonist %Inhib (Mean)
%Max (Mean)=-1.78%Agonist %Max (Mean)
%Max (Mean)=-1.438%Agonist %Max (Mean)
%Inhib (Mean)=-13.1%Antagonist %Inhib (Mean)
%Max (Mean)=-1.643%Agonist %Max (Mean)
%Inhib (Mean)=-12%Antagonist %Inhib (Mean)
%Inhib (Mean)=-43.54%Antagonist %Inhib (Mean)
%Max (Mean)=-2.23%Agonist %Max (Mean)
%Inhib (Mean)=-36.45%Antagonist %Inhib (Mean)
%Max (Mean)=-0.3693%Agonist %Max (Mean)
%Inhib (Mean)=-17.78%Antagonist %Inhib (Mean)
%Max (Mean)=-1.914%Agonist %Max (Mean)
%Inhib (Mean)=60.09%Antagonist %Inhib (Mean)
%Inhib (Mean)=70.16%Antagonist %Inhib (Mean)
%Max (Mean)=-1.07%Agonist %Max (Mean)
%Inhib (Mean)=-31.3%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Sphingosine 1-phosphate receptor 2
External ID: CHEMBL5121094
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Eur J Med Chem
Year: 2022
Volume: 227
First Page: 113923
Last Page: 113923
DOI: 10.1016/j.ejmech.2021.113923

Target ChEMBL ID: CHEMBL2955
ChEMBL Target Name: Sphingosine 1-phosphate receptor Edg-5
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard Units
4.44Kd=4440nM
4.98Kd=4980nM
4.15Kd=4150nM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Apelin receptor
External ID: CHEMBL5209815
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL1628481
ChEMBL Target Name: Apelin receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=59.98%Antagonist %Inhib (Mean)
%Max (Mean)=7.18%Agonist %Max (Mean)
%Inhib (Mean)=-8.64%Antagonist %Inhib (Mean)
%Inhib (Mean)=61.78%Antagonist %Inhib (Mean)
%Inhib (Mean)=-64.35%Antagonist %Inhib (Mean)
%Inhib (Mean)=-18.45%Antagonist %Inhib (Mean)
%Inhib (Mean)=-47.46%Antagonist %Inhib (Mean)
%Inhib (Mean)=-2.23%Antagonist %Inhib (Mean)
%Max (Mean)=19.78%Agonist %Max (Mean)
%Inhib (Mean)=-24.45%Antagonist %Inhib (Mean)
%Inhib (Mean)=-4.97%Antagonist %Inhib (Mean)
%Inhib (Mean)=25.24%Antagonist %Inhib (Mean)
%Inhib (Mean)=26.41%Antagonist %Inhib (Mean)
%Max (Mean)=7.91%Agonist %Max (Mean)
%Inhib (Mean)=6.32%Antagonist %Inhib (Mean)
%Inhib (Mean)=-4.11%Antagonist %Inhib (Mean)
%Inhib (Mean)=-15.95%Antagonist %Inhib (Mean)
%Inhib (Mean)=53.92%Antagonist %Inhib (Mean)
%Inhib (Mean)=15.92%Antagonist %Inhib (Mean)
%Inhib (Mean)=5.35%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Apelin receptor
External ID: CHEMBL5209814
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL1628481
ChEMBL Target Name: Apelin receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: D - Direct protein target assigned
Confidence: Direct single protein target assigned

Data Source: EUbOPEN Chemogenomic Library
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
%Inhib (Mean)=51.27%Antagonist %Inhib (Mean)
%Max (Mean)=-3.352%Agonist %Max (Mean)
%Inhib (Mean)=48.63%Antagonist %Inhib (Mean)
%Max (Mean)=15.2%Agonist %Max (Mean)
%Max (Mean)=0.339%Agonist %Max (Mean)
%Inhib (Mean)=-14.84%Antagonist %Inhib (Mean)
%Max (Mean)=-2.176%Agonist %Max (Mean)
%Inhib (Mean)=-17.21%Antagonist %Inhib (Mean)
%Inhib (Mean)=-3.54%Antagonist %Inhib (Mean)
%Max (Mean)=1.328%Agonist %Max (Mean)
%Inhib (Mean)=-25.88%Antagonist %Inhib (Mean)
%Max (Mean)=-1.284%Agonist %Max (Mean)
%Inhib (Mean)=-44.48%Antagonist %Inhib (Mean)
%Max (Mean)=-2.987%Agonist %Max (Mean)
%Inhib (Mean)=-2.87%Antagonist %Inhib (Mean)
%Inhib (Mean)=77%Antagonist %Inhib (Mean)
%Max (Mean)=-3.532%Agonist %Max (Mean)
%Inhib (Mean)=77.31%Antagonist %Inhib (Mean)
%Max (Mean)=-0.986%Agonist %Max (Mean)
%Inhib (Mean)=-19.81%Antagonist %Inhib (Mean)
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Transcription intermediary factor 1-alpha
External ID: CHEMBL5068965
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL3108638
ChEMBL Target Name: Transcription intermediary factor 1-alpha
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
Delta TM=-1.25CThermal Shift Assay